Cara Therapeutics reported $5.59M in Trade Creditors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 10.77M 3.89M
Acelrx Pharmaceuticals ACRX:US $ 2.72M 594K
Aerie Pharmaceuticals AERI:US $ 7.88M 0.41M
Cara Therapeutics CARA:US $ 5.59M 31K
Depomed DEPO:US $ 8.52M 1.84M
Endo International Ordinary Shares ENDP:US $ 101.01M 22.12M
Halozyme Therapeutics HALO:US $ 1.27M 0.28M
Horizon Pharma HZNP:US $ 67.01M 36.89M
JAZZ PHA JAZZ:US $ 73.34M 26.96M
Johnson & Johnson JNJ:US $ 9309M 1746M
Pacira Pharmaceuticals PCRX:US $ 14.84M 4.3M
Pain Therapeutics PTIE:US $ 3.33M 3.79M
Pfizer PFE:US $ 5506M 72M
Redhill Biopharma RDHL:US $ 16.93M 11.32M
Revance Therapeutics RVNC:US $ 10.02M 583K
Supernus Pharmaceuticals SUPN:US $ 12.32M 2.99M
Teva Pharmaceutical Industries TEVA:US $ 1750M 64M
Vanda Pharmaceuticals VNDA:US $ 5.1M 0.77M